|
||||||||||||||||
|
||||||||||||||||
Permit No LS036504 First prize |
Leukaemia Research
The important part research has played since 1983 is to identify over 50 different types of childhood leukaemia and cancer and through collaboration with the clinicians, specific treatment have been established. In January 1998 our Research Laboratory commenced work on further testing the link between the P16 gene and poor prognosis in leukaemia patients. It was found in our Laboratory that children whose cells contained the P16 gene had a better than 80% chance of survival. Those without the gene had only a 35% survival rate. If the link between the P16 and poor prognosis is proved internationally children with leukaemia will be screened for the gene at the time of diagnosis.
As you can well image the results of this study are of vital importance for the future treatment of children with leukaemia. This project represents an international collaboration as the specimens are being provided to our Laboratory by the Children's Cancer Group of Los Angeles, USA. The Children's Cancer Group is the largest co-operative clinical laboratory research group in the field of childhood cancer in the world. Hence the Laboratory as well as all our patients greatly benefit from being a member. Cell CultivationUnderpinning research into childhood cancer has been the Laboratory's success with cancer cell cultivation.
Institutes in England, The Netherlands, France, USA, Japan and the east coast of Australia have all been recipients of cell lines grown right here in WA.
|
|
||||||||||||||